 |
市場調査レポート
商品コード
1286019
オーソバイオロジクスの世界市場の規模、シェア、成長分析：製品別、用途別、最終用途別 - 産業予測（2023年～2030年）Global Orthobiologics Market Size, Share, Growth Analysis, By Product(Demineralized Bone Matrix, Allograft), By Application, By End-Use - Industry Forecast 2023-2030 |
||||||
| オーソバイオロジクスの世界市場の規模、シェア、成長分析：製品別、用途別、最終用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年04月29日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のオーソバイオロジクスの市場規模は、2022年の85億6,000万米ドルから2030年までに123億3,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで5.4％の成長が予測されています。予測期間中に市場の拡大を促進すると予測される2つの重大な理由は、スポーツ傷害と交通事故の発生の増加です。脊椎の疾患や障害の増加による市場の拡大が見込まれます。
当レポートでは、世界のオーソバイオロジクス市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターのファイブフォース分析
- 将来の混乱についての特別な考察
世界のオーソバイオロジクス市場：製品別
- 市場の概要
- 脱灰骨基質（DBM）
- 同種移植片
- 骨形成タンパク質（BMP）
- 関節内補充療法
- 合成代替骨・幹細胞療法
世界のオーソバイオロジクス市場：用途別
- 市場の概要
- 脊椎固定術
- 外傷修復
- 顎顔面・歯科
- 再建手術
世界のオーソバイオロジクス市場：最終用途別
- 市場の概要
- 病院
- 外来手術センター・整形外科クリニック
世界のオーソバイオロジクスの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主な成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Johnson & Johnson
- Stryker Corporation
- Medtronic plc
- Zimmer Biomet Holdings, Inc.
- DePuy Synthes
- NuVasive, Inc.
- Globus Medical, Inc.
- Orthofix Medical Inc.
- Wright Medical Group N.V.
- RTI Surgical, Inc.
- Bioventus LLC
- Seaspine Holdings Corporation
- Alphatec Holdings, Inc.
- Kuros Biosciences AG
- CONMED Corporation
- Xtant Medical Holdings, Inc.
- Amedica Corporation
- Cytomedix Inc.
- Histogenics Corporation
- Harvest Technologies Corporation
Orthobiologics Market size was valued at USD 7.63 billion in 2021 and is poised to grow from USD 8.56 billion in 2022 to USD 12.33 billion by 2030, growing at a CAGR of 5.4% in the forecast period (2023-2030).
Two significant reasons that are projected to fuel the expansion of the orthobiologics market during the forecast period are the increase in the incidence of traffic accidents and sports injuries. The market for orthobiologics is anticipated to expand as a consequence of the increase in spinal diseases and disorders. The increased patient preference for minimally invasive procedures is expected to impede the growth of the orthobiologics market. However, the cost of orthobiologics-based treatments is rising, which can limit the market's growth throughout the projection period. The surge in the number of old and obese people has caused the market for orthobiologics to grow more quickly than it did previously.
An alternative name for orthobiologics is regenerative cellular treatments. Growth factors are present in orthobiologic products, which lessen and stimulate discomfort, encourage tissue healing, and help the body return to normal function.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthbiologics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The Global Orthobiologics Market is segmented based on Product, Application, End-use and Region. Based on the Product, the Global Orthobiologics Market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes & Stem Cell Therapy. Based on the Application, the Global Orthobiologics Market is segmented into Spinal Fusion, Trauma Repair, Maxillofacial & Dental& Reconstructive Surgery. Based on End-Use, it is segmented into Hospitals, Ambulatory Surgical Centers& Orthopedic Clinics. Based on Region, it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Driver
To support the market, there is a considerable need for viscosupplements.
Knee osteoarthritis is a major problem for the elderly population and is well treated with viscosupplements. Viscosupplements, which are injections of hyaluronic acid, are administered directly into the joints. The main factors influencing the growth of the viscosupplements categories are high product costs, new manufacturer entry, and recent marketing approvals. Better reimbursement policies are also advantageous for the viscosupplements segments. Given the aforementioned factors, it is anticipated that during the forecast period, rising demand for viscosupplements will drive the growth of the global orthobiologics market.
An increase in the prevalence of illnesses and disorders
The market for orthobiologics is anticipated to expand as a consequence of the increase in spinal diseases and disorders. Additionally, it is anticipated that the market will grow as traffic incidents happen more frequently.
Restraint
The patient would rather receive treatment than have invasive treatments.
The need for minimally invasive procedures among patients is expected to limit the growth of the orthobiologics market. The adverse consequences of Bmp-based therapy could provide significant challenges for the orthobiologics business in the near future.
rising costs for therapies based on orthobiologics.
Additionally, it is predicted that the rise in the cost of therapies based on orthobiologics may impede the market's growth throughout the course of the projected year. Complex synthesis processes, manufacturing laws, and high production costs all place restrictions on the market. High prices and insufficient reimbursements for orthobiologics products and treatments are additional major factors restraining this market's expansion. The high cost of orthobiologics treatments and products is one of the main barriers preventing the growth of the global orthobiologics market.
Market Trends
The increased prevalence of sports-related injuries is expected to drive growth in the worldwide orthobiologics market. For instance, according to a study released in November 2018 and titled "Results on sports-related injuries in children from NHS emergency care dataset Oxfordshire pilot: an ecological study," 23.5 percent of admissions for all ages and 47.4 percent of emergency department visits were attributed to sports-related injuries.
On the international orthobiologics market, orthobiologics prices change often. According to a Sports Health article from October 2019, a University of Alabama at Birmingham study discovered that orthobiologics therapy can cost anywhere from a few hundred dollars to as much as US$ 12,000, for instance.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Orthobiologics Market by Product
- Market Overview
- Demineralized Bone Matrix (DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation
- Synthetic Bone Substitutes & Stem Cell Therapy
Global Orthobiologics Market by Application
- Market Overview
- Spinal Fusion
- Trauma Repair
- Maxillofacial & Dental
- Reconstructive Surgery
- Global Orthobiologics Market by End-Use
- Market Overview
- Hospitals
- Ambulatory Surgical Centers & Orthopedic Clinics
- Global Orthobiologics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NuVasive, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Globus Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthofix Medical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Medical Group N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Seaspine Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alphatec Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kuros Biosciences AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CONMED Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xtant Medical Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amedica Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cytomedix Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Histogenics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Harvest Technologies Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
